Arab Finance: Egyptian International Pharmaceutical Industries Co. (EIPICO) is aiming to achieve sales of EGP 4.8 billion this year, $54 million of which as exports, according to a press release on February 14^th.

The firm’s preliminary financial results showed that EIPICO achieved nearly EGP 4 million in sales last year, including exports worth $52 million, with a market cap of up to 25% of the total Egyptian exports.

In 2022, the company produced 320 million medicines packages, as well as launched 12 new products.

EIPICO is an Egypt-based public shareholding company that operates in the pharmaceutical industry. It is a manufacturer and exporter of pharmaceuticals and holds license agreements with a group of international.

Eastern Company sees 18% YoY higher profits in Q1 FY2025/26 Updated 12/28/2025 9:33:00 AM

Egypt’s agricultural exports reach 8.5M tons YTD Updated 11/30/2025 12:21:00 PM

Elsewedy Industrial Development, China's CJN to build $1B project in SCZONE Updated 11/27/2025 1:55:00 PM

El-Khatib reviews export burdens refund program’s budget Updated 11/26/2025 1:58:00 PM

Egyptian exports record $3.83B in October: El-Khatib Updated 11/23/2025 12:45:00 PM